AbCellera to Present at Upcoming Investor Conferences in March and April 2026

Audio By Carbonatix

VANCOUVER, British Columbia--(BUSINESS WIRE)--Feb 11, 2026--

AbCellera (Nasdaq: ABCL) today announced that the Company will present at the following investor conferences:

• TD Cowen 46th Annual Health Care Conference, March 4, 2026
• KeyBanc Capital Markets Healthcare Forum, March 17, 2026
• Bloom Burton & Co. Healthcare Investor Conference, April 21-22, 2026

A live audio webcast of each presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website closer to date. A replay will be available through the same link following the presentation.

About AbCellera Biologics Inc.

AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260210650979/en/

CONTACT: Inquiries

Media: Tiffany Chiu;[email protected], +1(236)521-6774

Partnering: Murray McCutcheon, Ph.D.;[email protected], +1(604)559-9005

Investor Relations: Peter Ahn;[email protected], +1(778)729-9116

KEYWORD: NORTH AMERICA CANADA

INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH PHARMACEUTICAL CLINICAL TRIALS ONCOLOGY

SOURCE: AbCellera Biologics Inc.

Copyright Business Wire 2026.

PUB: 02/11/2026 04:05 PM/DISC: 02/11/2026 04:06 PM

http://www.businesswire.com/news/home/20260210650979/en